Patients with IBD have highly heterogenic CD8+ T cell populations in their colons, which take on distinct phenotypes based on co‐stimulatory molecules, cytokine stimulation, and the degree of TCR‐antigen interaction [7, 8, 9]. The gene discussed is CD8A; the disease is inflammatory bowel disease.